A collection of all recent publications in peer-review journals and more.

  • Rationale, design, and methodology for the optimizing outcomes in women with gestational diabetes mellitus and their infants study.
    Berry DC, Neal M, Hall EG, Schwartz TA, Verbiest S, Bonuck K, Goodnight W, Brody S, Dorman KF, Menard MK, Stuebe AM.
    BMC Pregnancy Childbirth. 2013 Oct 10;13(1):184. [Epub ahead of print] 
  • The impact of uterine leiomyomas: a national survey of affected women.
    Borah BJ, Nicholson WK, Bradley L, Stewart EA.
    American Journal of Obstetrics and Gynecology. 2013;209:319.e1-20 (Epub ahead of print).
  • Prevention of mother-to-child HIV transmission within the continuum of maternal, newborn, and child health services.
    Chi BH, Bolton-Moore C, Holmes CB.
    Curr Opin HIV AIDS. 2013 Sep;8(5):498-503. doi: 10.1097/COH.0b013e3283637f7a. PubMed PMID: 23872611.
  • A Novel Approach for the Assessment of Distal Rectoceles.
    Crane AK, Geller EJ, Fenderson JL, Wells E, Myers E, Jannelli M, Connolly A, Matthews CA.
    [Abstract] Female Pelvic Med Reconstr Surg. 2013 Sept/Oct;19(5):S148. 
  • Prognosis of Children with HIV-1 Infection Starting Antiretroviral Therapy in Southern Africa: A Collaborative Analysis of Treatment Programs.
    Davies MA, May M, Bolton-Moore C, Chimbetete C, Eley B, Garone D, Giddy J, Moultrie H, Ndirangu J, Phiri S, Rabie H, Technau K, Wood R, Boulle A, Egger M, Keiser O; cfor the IeDEA Southern Africa (IeDEA-SA) Collaboration.
    Pediatr Infect Dis J. 2013 Dec 30. [Epub ahead of print] PubMed PMID: 24378936. 
  • Temporal Trends in the Characteristics of Children at Antiretroviral Therapy Initiation in Southern Africa: The IeDEA-SA Collaboration.
    Davies MA, Phiri S, Wood R, Wellington M, Cox V, Bolton-Moore C, Timmerman V, Moultrie H, Ndirangu J, Rabie H, Technau K, Giddy J, Maxwell N, Boulle A, Keiser O, Egger M, Eley B.
    PLoS One. 2013 Dec 9;8(12):e81037. doi: 10.1371/journal.pone.0081037. PubMed PMID: 24363808; PubMed Central PMCID: PMC3867284. 
  • Recommendations for cervical cancer prevention in sub-saharan Africa.
    Denny LA, Sankaranarayanan R, De Vuyst H, Kim JJ, Adefuye PO, Alemany L, Adewole IF, Awolude OA, Parham G, de Sanjosé S, Bosch FX.
    Vaccine. 2013 Dec 29;31 Suppl 5:F73-4. doi: 10.1016/j.vaccine.2012.11.077. PubMed PMID: 24331750.
  • The burden of human papillomavirus infections and related diseases in sub-saharan Africa.
    De Vuyst H, Alemany L, Lacey C, Chibwesha CJ, Sahasrabuddhe V, Banura C, Denny L, Parham GP.
    Vaccine. 2013 Dec 29;31 Suppl 5:F32-46. doi: 10.1016/j.vaccine.2012.07.092. PubMed PMID: 24331746. 
  • Cervical mucus monitoring prevalence and associated fecundability in women trying to conceive.
    Evans-Hoeker E, Pritchard DA, Long DL, Herring AH, Stanford JB, Steiner AZ.
    Fertil Steril. 2013 Oct;100(4):1033-1038.
  • Vaginal vs Robotic Hysterectomy: A Comparison of Postoperative Vaginal Length and Sexual Function. 
    Fenderson JL, Myers E, Liberty A, Geller EJ.
    J Minim Invasive Gynecol. 2013; 20(6):S105.
  • Changing trends in surgery for stress urinary incontinence.
    Geller EJ, Wu JM.
    Curr Opin Obstet Gynecol. 2013 Oct;25(5):404-9. doi: 10.1097/GCO.0b013e3283648cdd. PMID:23872710[PubMed - in process].
  • Perineal Body Length as Predictor of Anal Sphincter Injury at First Vaginal Delivery.
    Geller EJ, Robinson BL, Matthews CA, Celauro KP, Dunivan GC, Crane AK, Ivins RA, Woodham PC, Fielding JR.
    Int Urogynecol J. 2013 Dec 12. [Epub ahead of print]PMID: 24337585 [PubMed - as supplied by publisher]
  • Initial feasibility and acceptability of a comprehensive intervention for methamphetamine-using pregnant women in South Africa.
    Jones HE, Myers B, O’Grady KE, Gebhardt S, Theron GB, Wechsberg WM.
    Psychiatry J 2013;Article ID 929767. (month not available) 
  • Neonatal outcomes and their relationship to maternal buprenorphine dose during pregnancy.
    Jones HE, Dengler E, Garrison A, O’Grady KE, Seashore C, Horton E, Andringa K, Jansson LM, Thorp J.
    Drug Alc Depend 2014;134:414-7. 
  • The relationship between maternal methadone dose at delivery and neonatal outcome: methodological and design considerations.
    Jones HE, Jansson, LM, O'Grady KE, Kaltenbach, K.
    Neurotoxicol Teratol Sep/Oct 2013;39(1):110-5.
  • Anticholinergic medication use for female overactive bladder in the ambulatory setting in the U.S.
    Ju R, Garret J, Wu JM.
    Int Urogynecol J, 2013 Oct 25. [Epub ahead of print]. PMID:24158462.
  • Accelerating Ovarian Age: Cancer Treatment in the Premenopausal Woman.
    Letourneau JM, Chan SW, Rosen MP.
    Semin Reprod Med 2013;31(6):462-468.
  • Maternal mortality: time for national action.
    Main EK, Menard MK.
    Obstet Gynecol. 2013 Oct;122(4):735-6. doi: 10.1097/AOG.0b013e3182a7dc8c. No abstract available.
    PMID: 24084528 [PubMed - in process]
  • Utilization of cervical cancer screening services and trends in screening positivity rates in a 'screen-and-treat' program integrated with HIV/AIDS care in Zambia.
    Mwanahamuntu MH, Sahasrabuddhe VV, Blevins M, Kapambwe S, Shepherd BE, Chibwesha C, Pfaendler KS, Mkumba G, Vwalika B, Hicks ML, Vermund SH, Stringer JS, Parham GP.
    PLoS One. 2013 Sep 18;8(9):e74607. doi: 10.1371/journal.pone.0074607. PubMed PMID: 24058599; PubMed Central PMCID: PMC3776830. 
  • Interactive Web-Based Tool for Pelvic Organ Prolapse: Impact on Patient Understanding and Provider Counseling.
    Myers E, Robinson BR, Geller EJ, Wells E, Matthews CA, Fenderson JL, Crane AK, Jannelli M, Connolly A.
    J Minim Invasive Gynecol. 2013; 20(6):S57.
  • Outcomes of Total Robotic Hysterectomy vs Supracervical Hysterectomy with Sacrocolpopexy for Uterovaginal Prolapse at One Year. 
    Myers E, Siff L, Osmundsen B, Geller EJ, Matthews CA.
    J Minim Invasive Gynecol. 2013; 20(6):S179.
  • Response to Wouldes and Woodward: maternal methadone dose during pregnancy and infant clinical outcome.
    O’Grady KE, Jones HE, Jansson LJ, Kaltenbach K.
    Neurotoxicol Teratol Sep/Oct 2013;39(1):116-8.
  • Characteristics of Kenyan women in a prospective cohort study who continue using subdermal contraceptive implants at 12 months.
    O’Neill E, Tang J, Garrett J, Hubacher D.
    Contraception 2013. DOI: 10.1016/j.contraception.2013.11.016. Available online December 18, 2013.
  • Antiretroviral therapy restores age-dependent loss of resting memory B cells in young HIV-infected Zambian children.
    Rainwater-Lovett K, Nkamba H, Mubiana Mbewe M, Bolton Moore C, Margolick J, Moss W.
    J Acquir Immune Defic Syndr. 2013 Dec 8. [Epub ahead of print] PubMed PMID: 24326598.
  • Changes in measles serostatus among HIV-infected Zambian children initiating antiretroviral therapy before and after the 2010 measles outbreak and supplemental immunization activities.
    Rainwater-Lovett K, Nkamba HC, Mubiana-Mbewe M, Bolton- Moore C, Moss WJ.
    J Infect Dis. 2013 Dec 1;208(11):1747-55. doi: 10.1093/infdis/jit404. Epub 2013 Aug 2. PubMed PMID: 23911708; PubMed Central PMCID: PMC3814842. 
  • When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa.
    Schomaker M, Egger M, Ndirangu J, Phiri S, Moultrie H, Technau K, Cox V, Giddy J, Chimbetete C, Wood R, Gsponer T, Bolton Moore C, Rabie H, Eley B, Muhe L, Penazzato M, Essajee S, Keiser O, Davies MA; International Epidemiologic Databases to Evaluate AIDS–Southern Africa (IeDEA-SA) Collaboration.
    PLoS Med. 2013 Nov;10(11):e1001555. doi: 10.1371/journal.pmed.1001555. Epub 2013 Nov 19. PubMed PMID: 24260029; PubMed Central PMCID: PMC3833834. 
  • Hormonal contraception and HIV: the methods have confused the message.
    Schwartz SR, Pettifor A, Stuart GS, Cohen MS.
    AIDS. 2013 Oct; 27 (Suppl 1): S45-S53. 
  • Urinary incontinence and treatment-seeking behaviors.
    Siddiqui NY, Ammarell N, Wu JM, Sandoval JS, Bosworth HB.
    [Abstract] Female Pelvic Med Reconstr Surg. 2013 Sept/Oct; 19(5 Supp):S52. 
  • The Burden of Uterine Fibroids for African-American Women: Results of a National Survey.
    Stewart EA, Nicholson WK, Bradley L, Borah BJ.
    J Womens Health (Larchmt). 2013 Oct;22(10):807-816. Epub 2013 Sep 14.
  • Safe pregnancy in the world's poorest countries begins with access and ends with the obstetricians.
    Stringer JS.
    Obstet Gynecol. 2013 Sep;122(3):515-6. doi: 10.1097/AOG.0b013e3182a38bf3. PubMed PMID: 23921853. 
  • Patient Characteristics Associated with Treatment Choice for Pelvic Organ Prolapse and Urinary Incontinence.
    Sullivan S, Davidson E, Bretschneider E, Liberty A, Geller, EJ.
    [Abstract] Female Pelvic Med Reconstr Surg. 2013 Sept/Oct;19(5):S85. 
  • Short Communication: Late Refills During the First Year of Antiretroviral Therapy Predict Mortality and Program Failure Among HIV-Infected Adults in Urban Zambia.
    Vinikoor MJ, Schuttner L, Moyo C, Li M, Musonda P, Hachaambwa LM, Stringer JS, Chi BH.
    AIDS Res Hum Retroviruses. 2014 Jan;30(1):74-7. doi: 10.1089/AID.2013.0167. Epub 2013 Aug 30. PubMed PMID: 23924188. 
  • Adverse pregnancy outcomes following motor vehicle crashes.
    Vladutiu CJ, Marshall SW, Poole C, Casteel C, Menard MK, Weiss HB.
    Am J Prev Med. 2013 Nov;45(5):629-36. doi: 10.1016/j.amepre.2013.06.018.
    PMID: 24139777 [PubMed - in process] 
  • Perioperative anticholinergic medications and risk of failed void trial after urogynecologic surgery.
    Walter PJ, Dieter AA, Siddiqui NY, Weidner AC, Wu JM.
    [Abstract] Female Pelvic Med Reconstr Surg. 2013 Sept/Oct; 19(5 Supp):S63. 
  • Tenofovir or zidovudine in second-line antiretroviral therapy after stavudine failure in southern Africa.
    Wandeler G, Gerber F, Rohr J, Chi BH, Orrell C, Chimbetete C, Prozesky H, Boulle A, Hoffmann CJ, Gsponer T, Fox MP, Zwahlen M, Egger M, Africa IS.
    Antivir Ther. 2013 Dec 3. doi: 10.3851/IMP2710. [Epub ahead of print] PubMed PMID: 24296645.
  • Systematic review of the genetic epidemiology of pelvic organ prolapse in women.
    Ward RM, Velez Edwards DR, Edwards T, Giri A, Jerome RN, Wu JM.
    [Abstract] Female Pelvic Med Reconstr Surg. 2013 Sept/Oct; 19(5 Supp):S97
  • Lifetime risk of surgery for stress incontinence and pelvic organ prolapse.
    Wu JM, Matthews CA, Jonsson Funk M.
    [Abstract] Female Pelvic Med Reconstr Surg. 2013 Sept/Oct; 19(5 Supp):S59.
  • Simultaneous detection of major drug resistance mutations in the protease and reverse transcriptase genes for HIV-1 subtype C by use of a multiplex allele-specific assay.
    Zhang G, Cai F, Zhou Z, DeVos J, Wagar N, Diallo K, Zulu I, Wadonda-Kabondo N, Stringer JS, Weidle PJ, Ndongmo CB, Sikazwe I, Sarr A, Kagoli M, Nkengasong J, Gao F, Yang C.
    J Clin Microbiol. 2013 Nov;51(11):3666-74. doi: 10.1128/JCM.01669-13. Epub 2013 Aug 28. PubMed PMID: 23985909. 
    Filed under: